IC
QNRX

Ikarian Capital’s Quoin Pharmaceuticals QNRX Stock Holding History

Ikarian Capital’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Hold
211,538
– – 0.11% 107
2025
Q4 		$3.05M Buy
+211,538
New +$2.88M 0.24% 84
2025
Q1 		– Sell
-7,857
Closed -$179K – 205
2024
Q4 		$179K Buy
+7,857
New +$180K 0.02% 151

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ikarian Capital's QNRX Position: Q1 2026 in Review

Ikarian Capital held its Quoin Pharmaceuticals (QNRX) position steady in Q1 2026 at 211,538 shares worth $1.4M. The position accounts for 0.11% of the portfolio, ranked #107.

Ikarian Capital first reported a position in QNRX in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.05M in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Ikarian Capital held 211,538 shares of Quoin Pharmaceuticals worth $1.4M as of Q1 2026.
  • Ikarian Capital left its Quoin Pharmaceuticals share count unchanged in Q1 2026.
  • Quoin Pharmaceuticals made up 0.11% of Ikarian Capital's portfolio in Q1 2026, its #107 holding.
  • Ikarian Capital first reported a position in Quoin Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Ikarian Capital's Quoin Pharmaceuticals position peaked at $3.05M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.